- Country: Brazil
- Summary: Price Registration for Possible Acquisition of Medicines - Legal Demand. Protocol N 20.721.839-1
- BRT Ref No: 89922519
- Deadline: 25 Oct 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 417/2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Price Registration for eventual acquisition of medicines - legal demand. Protocol n 20.721.839-1
UASG Code: 456793
Notice from: 03/10/2023 from 08:00 to 17:59
Proposal Delivery: from 03/10/2023 at 08:00
ABEMACICLIBE, CONCENTRATION 150 MG
19981d172c851bd4e8a1788d5726c2d3Quantity: 40320
ACALABRUTINIB, CONCENTRATION 100 MG
Quantity: 4320
CARGLUMIC ACID, CONCENTRATION 200 MG, PHARMACEUTICAL FORM TABLET FOR SUSPENSION
Quantity: 5040
ARSENIC TRIOXIDE, CONCENTRATION 2 MG/ML, PHARMACEUTICAL FORM SOLUTION FOR INFUSION
Quantity: 612
ATEZOLIZUMAB, CONCENTRATION19981d172c851bd4e8a1788d5726c2d3O 60 MG/ML, PHARMACEUTICAL FORM SOLUTION FOR INFUSION
Quantity: 96
DARATUMUMAB, CONCENTRATION 120 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 96
DURVALUMAB, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity age: 240
DURVALUMAB, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM19981d172c851bd4e8a1788d5726c2d3INJECTABLE SOLUTION
Quantity: 96
EMICIZUMAB, CONCENTRATION 150 MG/ML, INJECTABLE PHARMACEUTICAL FORM
Quantity: 48
FREMANEZUMAB, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL FILLED SYRINGE
Quantity: 72
HEMINA, CONCENTRATION* 350 MG, PHARMACEUTICAL FORM LYOPHIL POWDER19981d172c851bd4e8a1788d5726c2d3FOR INJECTABLE
Quantity: 48
LANADELUMAB, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 48
NATALIZUMAB, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 48
NINTEDANIB, SALT AND COMPOSITION SILATE, CONCENTRATION 100 MG
Quantity: 1440
NITISINONA, CON19981d172c851bd4e8a1788d5726c2d3CENTRATION 20 MG
Quantity: 1440
OBINUTUZUMAB, CONCENTRATION 25 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 72
OFATUMUMAB, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL FILLED SYRINGE ATTACHED TO APPLICATOR PEN
Quantity: 96
TERIFLUNOMIDE, CONCENTRATION19981d172c851bd4e8a1788d5726c2d314 MG
Quantity: 720
UPADACITINIBE, C... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPrice Registration for Possible Acquisition of Medicines - Legal Demand. Protocol N 20.721.839-1 - Brazil Tender
The PARANA STATE HEALTH FUND, a Government sector organization in Brazil, has announced a new tender for Price Registration for Possible Acquisition of Medicines - Legal Demand. Protocol N 20.721.839-1. This tender is published on BrazilTenders under BRT Ref No: 89922519 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-10-25.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
